CLMB vs JAZZ · P/E 27, rev $356.6M vs P/E 1988, rev $2.28B
Climb Global Solutions (CLMB) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Climb Global Solutions (CLMB) is a electronics & computer distribution company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported CLMB revenue for 2026-06-30 was $356.6M. Net income was $8.9M. Revenue was up 95.5% from 2026-03-31 to 2026-06-30. CLMB currently screens at market cap $534.9M and trailing P/E 27.2.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
CLMB currently screens at market cap $534.9M and trailing P/E 27.2. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the CLMB and JAZZ stock pages for the full models.
Not investment advice.